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The prevalence and variety of neoplastic diseases in wild-
life are likely under-reported and are certainly understud-
ied. Phenotypically similar forms of cancer exist across 
disparate species, underscoring the universal nature of 
cancer. A better understanding of both shared and unique 
aspects of cancer across wildlife species will undoubtedly 
shed light on potential mechanisms of oncogenesis. This 
comparison may even untangle some of the complexities 
regarding human cancer. Certainly, the large number of 
animal populations inhabiting distinct environments pro-
vide many natural ‘experiments’ such as that examined 
by Mǿller et al.1, where cancer in a broad spectrum of 
bird species was shown to be tightly linked to the natu-
ral history and immunity of each species. Wild animals 
are profoundly influenced not only by selective pressures 
within their own species but also by their interface with 
humans. Information gained from monitoring diseases in 
free-ranging wildlife is of paramount importance, as we 
often occupy the same habitat. A growing human popula-
tion places increasing demand on many shared resources. 
For example, globally, water resources are being limited by 
both access (human development) and a shrinking sup-
ply, so that the demand for adequate wastewater treatment 
will become increasingly important over the coming dec-
ades (Fig. 1). Furthermore, an increasing human popula-
tion will usher in global changes that wildlife already face, 
such as crowding, mixing of subpopulations and increased 
environmental complexity. How these changes modulate 
the pathophysiology of cancer in wildlife species will also 
be extremely important to identify, as the implications for 
wildlife and human health are likely to be similar.
This Review describes some of the cancers affecting 
wildlife populations and what we know about the role of 
infectious agents, environmental toxins and reproductive 
or metabolic disturbances in contributing to the onco-
genic processes (Table 1). Although neoplasia occurs in 
nearly all multicellular organisms2, this Review primarily 
addresses instances of such disease in wild vertebrates. 
We also describe new examples of spontaneous cancers 
that have been identified in both captive and wildlife spe-
cies since the potential impact of cancer on wildlife was 
first reviewed by McAloose and Newton3. Such diseases 
are an increasing concern for protected and endangered 
species and are a unique frame of  reference for pressures 
that drive neoplastic transformation.
Pathogen-driven cancer
Infections in humans are considered causal for approxi-
mately 15% of the global cancer burden2. Owing to a lack 
of vigilant screening, which is often applied to human 
cancer, the number of wildlife cancers caused by infec-
tion is not known, nor has it been possible to determine 
whether the number of cancers associated with patho-
gens is similar in humans and wildlife. However, there 
Cancer in wildlife: patterns of 
emergence
Patricia A. Pesavento1*, Dalen Agnew2, Michael K. Keel1 and Kevin D. Woolard1
Abstract | Cancer is ubiquitous in wildlife, affecting animals from bivalves to pachyderms and 
cetaceans. Reports of increasing frequency demonstrate that neoplasia is associated with 
substantial mortality in wildlife species. Anthropogenic activities and global weather changes are 
shaping new geographical limitations for many species, and alterations in living niches are 
associated with visible examples of genetic bottlenecks, toxin exposures, oncogenic pathogens, 
stress and immunosuppression, which can all contribute to cancers in wild species. Nations that 
devote resources to monitoring the health of wildlife often do so for human-centric reasons, 
including for the prediction of the potential for zoonotic disease, shared contaminants, chemicals 
and medications, and for observing the effect of exposure from crowding and loss of habitat. 
Given the increasing human footprint on land and in the sea, wildlife conservation should also 
become a more important motivating factor. Greater attention to the patterns of the emergence 
of wildlife cancer is imperative because growing numbers of species are existing at the interface 
between humans and the environment, making wildlife sentinels for both animal and human 
health. Therefore, monitoring wildlife cancers could offer interesting and novel insights into 
potentially unique non-age-related mechanisms of carcinogenesis across species.
1Department of Pathology, 
Microbiology, and 
Immunology, School of 
Veterinary Medicine, 
University of California, 
Davis, CA, USA.
2Veterinary Diagnostic 
Laboratory, Department of 
Pathobiology and Diagnostic 
Investigation, College of 
Veterinary Medicine, 
Michigan State University, 
East Lansing, MI, USA.
*e-mail: papesavento@
ucdavis.edu
https://doi.org/10.1038/ 
s41568-018-0045-0
www.nature.com/nrc
R e v i e w s
646 | OCTOBER 2018 | vOlumE 18 
is sound reasoning to hypothesize that wildlife might 
harbour an even greater burden of pathogen-associated 
cancer as a result of multiple factors, such as a lack of 
prophylaxis, higher burden of infectious disease, chronic 
stress and crowding. Despite research lagging in the 
identification of oncogenic microorganisms (viruses, 
bacteria or parasites) in domestic and non-domestic 
animal species, recent molecular strategies have been 
successful in revealing not only microorganism associa-
tion with certain wildlife cancers but also interesting and 
novel patterns of pathogenesis.
Paradoxically, cancers associated with microorgan-
isms were first described in animals, and subsequent 
research led the way for recognition of this common 
mechanism of oncogenesis in humans4. Studies of 
cancers with an infectious origin have provided insights 
into cell proliferation and pathogen lifestyles that chal-
lenged pre-existing dogmas of pathogen-driven diseases 
(box 1); however, proving transformation by a pathogen 
in the laboratory versus a naturally occurring infection in 
the wild is quite distinct5,6. Therefore, uncovering 
pathogen-driven oncogenesis is challenging, even with 
extensive epidemiology and considerable research invest-
ment. For example, documenting the role of human pap-
illomavirus (PV) in cervical cancer beyond a reasonable 
doubt or as a necessary cause took almost 50 years of 
epidemiology, seroepidemiology, molecular investigation 
and pathogenesis studies7. Despite the sizeable challenges 
in demonstrating causality in wildlife disease, these types 
of studies provide valuable insight for global health.
1950 2017
Growth in suburbia
In human populated areas, there 
is exposure to agricultural, 
landscaping, food, drug and 
sewage contaminants.
Transport links limit roaming 
range and could limit mating 
choices, which has the 
potential to create genetic 
bottlenecks, even in 
non-endangered species.
Consistent water sources are important and can 
be either non-treated or treated. Treated water 
can be inappropriate for drinking.
Are animals in suburbia 
more or less stressed than 
their wild counterparts? 
Research on the effects of 
stress in wildlife is limited.
Exposure to pathogens, including 
those able to infect multiple host 
species, is more common in densely 
populated areas.
Coexistence of multiple species generates an 
intensive human–wildlife interface in which 
several  species share shelter, water and food. 
Poison
Fig. 1 | Oncogenic pressures at the human–animal interface using suburbia as an example. Suburbs or residential areas 
are an expanding and unique living niche for wildlife. The figure shows the USA , where there has been a large and rapid 
growth in suburbia from the 1950s until today. The pale orange areas depict the expansion from major and smaller cities 
(grey). Raccoons, foxes, opossums and other mesopredators are much denser in population in suburban areas than in any 
rural or wild landscape. Animals that live in suburbia share food and water sources, such as domestic waste, cat food, 
fountains, sprinklers and feeders, with domestic animals and humans. Access to food and water is dictated by man-made 
structures, such as roads, buildings or railways, that restrict natural roaming ranges. For example, raccoons in the wilderness 
range up to 12,000 acres, whereas in suburbia in the USA , their range is only 3–4 blocks (the smallest area that is surrounded 
by streets). Given these limitations in roaming, there is considerable potential for creating genetic islands or bottlenecks, 
even in this non-endangered species. Higher population densities (of animals and humans) can support pathogen exposure, 
stress, pathogen load and cross-species transmission. Pathogens that can jump species, for example, canine parvovirus and 
canine distemper virus, could hypothetically be very successful in this intensive housing situation. Infection with both of these 
pathogens can result in immunosuppression in the host and could, therefore, alter lifetime immunity to oncogenic pathogens.
Canine distemper virus
an enveloped single-stranded 
negative RNa virus of the 
family Paramyxoviridae related 
to the viruses that cause 
measles in humans. it is also 
referred to as carnivore 
distemper virus, as it causes 
systemic disease in a wide 
variety of animal families, 
including domestic and wild 
dogs, coyotes, foxes, pandas, 
wolves, ferrets, skunks, 
raccoons, large cats and 
pinnipeds.
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There are multiple, non-mutually exclusive and 
potentially converging mechanisms by which patho-
gens can drive oncogenic transformation. These include 
chronic inflammation, with progression to hyperplasia 
and neoplasia; expression of viral proteins that orches-
trate cell proliferation, cell death and/or metabolic path-
ways; and direct integration of the viral genome leading 
to mutagenesis. Examples of all these mechanisms occur 
among wildlife species.
Chronic inflammation to neoplasia
Chronic inflammatory responses as a result of pathogen 
infection can predispose a targeted tissue to cancer, and 
untreated persistent infections are common in wild-
life8. This type of cellular transformation is considered 
to occur through a combination of DNA damage and 
pro-inflammatory factors9; however, this is likely to be an 
oversimplification. For example, genetic damage, expo-
sure to carcinogens and chemokine expression during 
Table 1 | Notable examples of neoplasia in wildlife species and their associated aetiologies
Species Cancer type Aetiology Refs
Atlantic salmon (Salmo salar) Leiomyosarcoma Retrovirus (unknown species) 7,9,75
Beluga whale (Delphinapterus leucas) Gastric papilloma Organochlorine intoxication 90
Bighorn sheep (Ovis canadensis) Nasal carcinoma and myxomatous 
fibromas
Unknown; suspected retrovirus 69,70
Bottlenose dolphin (Tursiops truncatus) Lymphoma Dioxins suspected 100
California sea lion (Zalophus californianus) Urogenital carcinoma Multifactorial; otarine herpesvirus 1 
involvement; organochlorines, polyaromatic 
hydrocarbons and a genetic basis (loss of 
polymorphism at a single locus, the HPSE2 
gene) also suspected
49–56
Santa Catalina island fox (Urocyon littoralis 
catalinae)
Ceruminous gland tumours Otodectes cynotis (ear mite; through chronic 
inflammation and epithelial hyperplasia)
14
Deer (Capreolus sp., Odocoileus sp. and 
Ranger sp.)
Cutaneous fibropapillomas and 
cutaneous fibromas
Deltapapillomavirus 46
Fallow deer (Dama dama) Endometrial carcinoma, cervical 
carcinoma and leiomyomas
Presumed continuous hormonal stimulation in 
unbred geriatric individuals free from predation
D.A., 
unpublished 
data
Giraffe (Giraffa camelopardalis) Fibropapillomas (sarcoids) Deltapapillomavirus 46
Jaguar (Panthera onca) Ovarian, endometrial and mammary 
carcinoma
Unknown pathogenesis: presumably heritable 
mutations
120–124
Koala (Phascolarctos cinereus) Lymphoma Koala retrovirus B 71–74
Mountain gorilla (Gorilla beringei) B cell lymphoma Gibbon lymphocryptovirus 1 64
Northern fulmar (Fulmarus glacialis) Mesenchymal neoplasm Papillomavirus 47
Raccoon (Procyon lotor) Brain neuroglial tumours Raccoon polyomavirus 24,25,29,30
Ring-necked pheasant (Phasianus colchicus) Intestinal sarcoma (undetermined cell 
of origin)
Chronic typhlocolitis associated with Heterakis 
gallinarum (a nematode)
16
Sea turtle (All species; most prevalent in 
Chelonia mydas)
Fibropapillomas Suspected alphaherpesvirus 57–63
Soft-shelled clam (Mya arenaria) Clam leukaemia Transmission of clonal malignant haemocytes 152
South American fur seal (Arctocephalus australis) Urogenital carcinoma Otarine herpesvirus 1 53
Tapir (Tapirus sp.) Fibropapillomas (sarcoids) Deltapapillomavirus 46
Tasmanian devil (Sarcophilus harrisii) Devil facial tumour disease Clonal transmissible tumour cells 146–151
Walleye fish (Sander vitreus) Dermal sarcoma Epsilon retrovirus 76,77
Water buffalo (Bubalus arnee) Fibropapillomas (sarcoids) Deltapapillomavirus 46
West Indian manatee (Trichechus manatus) Uterine leiomyomas Unknown 133
Western barred bandicoot (Perameles 
bougainville)
Papillomas and squamous cell 
carcinoma
Bandicoot papillomatosis carcinomatosis virus 
type 1
42,43
White rhinoceros (Ceratotherium simum) and 
Indian rhinoceros (Rhinoceros unicornis)
Uterine leiomyomas Presumed continuous hormonal stimulation in 
unbred captive individuals
129,130
White suckers (Catostomus commersonii) Hepatic and biliary neoplasia EDCs suspected 101
White-tailed deer (Odocoileus virginianus) Urothelial carcinoma Unknown 157
Wolves, coyotes and jackals (Canis spp.) Transmissible venereal tumour 
(oronasal and genital mucosa)
Clonal transmissible tumour cells 141–144
Zebra (Equus spp.) Fibropapillomas (sarcoids) Deltapapillomavirus 46
EDCs, endocrine-disrupting compounds; HPSE2, inactive heparanase 2.
www.nature.com/nrc
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destruction, but chronic infestation can be associated 
with cancer. Inflammation associated with the ear mite 
(Otodectes cynotis) has been implicated in the develop-
ment of ceruminous gland hyperplasia and carcinoma in 
feral, adult Santa Catalina Island foxes (Urocyon littoralis 
catalinae)14. This is an important discovery in the unique 
circumstance in which the fox population is isolated on 
a single island and can therefore be tracked and treated. 
Because these foxes are Near Threatened (International 
Union for Conservation of Nature (IUCN) Red List), 
a field trial was conducted to assess the impact of treat-
ment of ceruminous gland hyperplasia with the pes-
ticide acaricide, which kills ticks and mites15. Initially, 
these foxes had a 100% mite infestation rate, half of 
which developed ear tumours. Treatment significantly 
reduced hyperplasia compared with untreated controls15. 
The researchers proposed that the long-term presence 
of mites is associated with epithelial hyperplasia, and 
in support of causality, removal of the parasite burden 
resulted in reversal of tumour development. Ultimately, 
these findings have altered management decisions, 
chronic gastritis in humans are all considered mecha-
nisms for bacterial Helicobacter-associated gastric car-
cinoma and B cell lymphoma10. Yet, H. pylori-encoded 
cytotoxicity-associated immunodominant antigen 
(CagA) can directly manipulate host proliferation and 
apoptotic pathways11,12. Chronic gastritis associated 
with Helicobacter infection that results in adenocarci-
noma has been reproduced under laboratory condi-
tions in infected ferrets (Mustela putorius furo), gerbils 
(Meriones unguiculatus) and hamsters (Mesocricetus 
auratus), and there is some evidence to suggest that 
mucosa-associated lymphoid tissue (MALT) lymphoma 
is associated with H. heilmannii infection in big cats 
such as tigers (Panthera tigris) and cheetahs (Acinonyx 
jubatus)13. Taken together, the available data suggest that 
susceptibility to inflammation and subsequent neoplasia 
vary among different hosts as well as among different 
Helicobacter species.
Wild animals commonly have a burden of macro-
parasites (such as helminths and arthropods). The con-
sequences of infestation can be direct, such as tissue 
Box 1 | Oncovirus–host co-evolution
viral taxonomists estimate that for most persistent 
oncogenic viruses, co-evolution with their host animal 
lineage has occurred slowly over millions of years.  
For example, papillomaviruses (Pvs) are an ancient virus 
group containing 49 genera and over 300 virus species in 
animals ranging from fish to marine birds and mammals 
(http://pave.niaid.nih.gov/).
In the vast majority of Pv infections, the infected host 
does not exhibit noticeable symptoms, but disruption of 
this apparently metastable coexistence can occur, for 
example, under conditions of immunosuppression. 
unfortunately, a lack of widespread infection in healthy 
animals has limited our understanding of how persistent 
infections become oncogenic or have other potential 
sequelae. There is also no experimental model that can 
provide insights into the often decades-long metastable 
state of a potentially oncogenic viral infection.
Koch’s postulates for establishing a relationship between 
a pathogen and a given disease are based upon the criteria 
that the pathogen should cause disease in all infected 
individuals and that the disease is not caused by other 
agents168. As Pvs, polyomaviruses and herpesviruses 
typically infect the entire human population and cause 
cancer in, at most, only a small fraction of infected 
individuals, they cannot be explained by Koch’s postulates. 
Cancer virology has instead utilized Hill’s criteria for 
causation, whereby the more certain an association 
between a factor and an effect is, the greater the probability 
it is a causal relationship, an example of this being the 
finding that viral sequences are associated with particular 
forms of cancer169. Careful analysis of outbreaks and 
species-specific cancers can identify tumour-associated 
pathogens, and although we cannot infer causation lightly, 
they do provide insight into host susceptibility, the 
environment and the evolution of pathogens.
The image in part a shows the ultrastructure of a 
chondroblast surrounded by scant chondroid matrix from 
a seabird infected with an avian Pv. In part b, a higher 
power magnification of part a, paracrystalline arrays of Pv 
(virus diameter 46–48 nm) can be seen in the nucleus.  
Scale bar = 2 μm.
a
b
NATuRE REvIEwS | CANCeR
R e v i e w s
  vOlumE 18 | OCTOBER 2018 | 649
with any fox caught during routine trapping now being 
treated with acaricide.
In another example, ring-necked pheasants 
(Phasianus colchicus) with intestinal nematode infesta-
tion (Heterakis spp.) frequently develop severe nodular 
typhlocolitis, a chronic inflammatory condition that can 
develop into local and metastatic sarcomas16. These have 
been primarily identified in captive pheasants, suggest-
ing contributions from stress, higher parasite loads and 
altered diets16.
Direct cell transformation
In tissue culture, cellular transformation can be achieved 
by disruption of a limited number of cellular regulatory 
pathways17. Some viruses encode proteins that can target 
regulatory pathways and disrupt cell cycle, metabolic or 
apoptotic control, which can all contribute to transforma-
tion. There are commonalities among oncogenic patho-
gens that directly transform cells and that have served as 
a guide for oncogenic viral discovery. These common-
alities are that pathogens associated with cancer have 
been persistent (usually lifelong) infections, regardless 
of their host species; transformation is rare as a sequela of 
infection compared with the prevalence of infected hosts 
and is most likely to occur in immunosuppressed ani-
mals; and either tissue stem cells are the initial target cells 
of oncogenic viruses or ‘stemness’ results from infection. 
However, these are generalizations and not limited, 
among pathogens, to viruses, although viruses form the 
vast majority of oncogenic pathogens. The causal onco-
genic viral families that have emerged, in all animals 
and humans, include Papillomaviridae, Polyomaviridae, 
Retroviridae and Herpesviridae. Reduced genetic diver-
sity that arises when a new population is formed from a 
small number of individuals from a much larger popula-
tion (known as the founder effect) appears to have impli-
cations for susceptibility to pathogens that can result in 
neoplasia. For example, more highly inbred California 
sea lions (Zalophus californianus) are susceptible to bac-
terial infection, helminthiasis, intoxication by harmful 
algal blooms and neoplasia; among these susceptibilities, 
the highest correlation was observed between the degree 
of genetic relatedness and the presence of urogenital car-
cinoma18. However, it should be noted that the overriding 
mechanism for urogenital carcinogenesis in California 
sea lions is not yet known, and development of these 
tumours could involve virus infection, environmental 
toxins or a combination of these and other factors.
Polyomaviruses and papillomaviruses. Polyomavirus 
(PyV) infections appear nearly ubiquitous in wildlife 
and have been identified in mammals, invertebrates, 
fish, amphibians, reptiles and birds19. Well-studied PyVs 
include the simian virus 40 (SV40) and murine PyV in 
laboratory animals and Merkel cell PyV (MCPyV), JC 
PyV and BK PyV in humans20,21. All PyVs encode the 
potentially oncogenic tumour antigen (T antigen or T Ag) 
proteins, which have a pivotal function in both virus 
replication and control of the host cell cycle19,21. On the 
basis of experimental studies, many viruses in this family 
cause tumours in immunosuppressed animals, but the 
vast majority of naturally occurring infections are clin-
ically silent, with exceedingly rare transformation20,21. 
Examples of tumours caused by PyV infection include 
Merkel cell skin carcinomas in humans22,23 (box 2), brain 
tumours in wild raccoons (Procyon lotor)24,25 and a 
 variety of tumours in laboratory animal species26–28.
Raccoon polyomavirus (RacPyV) associated with the 
occurrence of cancer was first reported in 2013 (ReF.24). 
There is now strong evidence that RacPyV causes a series 
of recently identified, naturally occurring neuroglial 
tumours in raccoons. Tumours in raccoons are not com-
mon, but to date, 23 cases of tumours have been recorded 
on the West Coast of the USA and Canada29. It is unlikely 
that these tumours occurred before 2013, because nec-
ropsy, including evaluation of the brain, is commonly 
performed on raccoons in many diagnostic laboratories 
in the USA because they are known to carry rabies on 
the East Coast. In 3 years (2013–2016), the number of 
raccoons with tumours represented 15% of the total 
number of raccoons that had necropsies performed 
regionally (northern California, USA). The number is 
heavily biased because animals submitted for necropsy 
evaluation are more likely to have clinical signs referable 
to the neurological system and to be unafraid of humans 
but is notably high nonetheless in the context of the pre-
vious and fairly consistent screening by necropsy. The 
tumours are invariably found crossing the nasal–brain 
barrier and affecting the olfactory tract and frontal brain 
lobes24. RacPyV has been detectable in all the identified 
tumours to date and is present in high copy number as 
measured by both quantitative PCR and in situ hybridi-
zation25,30. Metastases occurred in only a single case, and 
virus was detectable in all neoplastic cells, within all met-
astatic foci. Primary cell culture studies suggest that the 
target cell of transformation is the multipotent neuroglial 
stem cells of the subventricular zone of the brain30 (Fig. 2).
Transcriptome analyses have revealed that T Ags are 
highly expressed in these tumours, but structural genes 
Box 2 | Merkel cell polyomavirus
merkel cell polyomavirus (mCPyv) is a common, almost universal infection in humans170. 
In rare cases, mCPyv is found to be the cause of a very aggressive form of skin cancer 
called merkel cell carcinoma, where viral DNA is integrated into the tumour genome27.
Approximately half of the mCPyv genome encodes structural viral proteins (vPs), and 
the other half encodes viral tumour antigens (T antigens or T Ags). Among several 
established criteria for causality is the key finding that vP expression is uncoupled 
(absent) compared with the dysregulated or upregulated expression of T Ags. Expression 
of a T Ag alone is sufficient, in experimental models, to drive tumour formation20. Several 
viral T Ag–host protein interactions occur, among which are the binding and inhibition of 
the tumour suppressors RB, p53 and protein phosphatase 2A (PP2A) (see the figure).
Analyses of the genomes of polyomaviral-associated versus non-viral-associated 
merkel cell tumours have demonstrated that virus-negative tumours have a high burden 
of somatic gene mutations, whereas mCPyv-positive tumours have few. Presumably, the 
T Ags of mCPyv are capable of efficiently hijacking cellular processes to drive 
tumorigenesis in a manner that is comparable to inducing somatic gene alterations23.
p53 binding site
Origin binding
domain
RB
binding siteDnaJ
PP2A
binding site
HelicaseCR1
www.nature.com/nrc
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have exceptionally low expression30. This is highly rele-
vant with regards to estimating viral causality because 
uncoupling of the oncogenic T Ag from capsid protein 
expression is a common prerequisite for transforma-
tion in known PyV-driven cancers22. In at least four of 
the raccoon tumours, RacPyV was episomal; therefore, 
exactly how capsid protein expression is suppressed is 
unknown, but the virome is both stable and abundant in 
the tumours analysed so far25. Among the many known 
PyV infections that have been identified in the animal 
kingdom, the reason why RacPyV infection in raccoons 
results in brain cancer is still enigmatic. Infections in rac-
coons, at least by serosurveillance, are widespread29, but 
tumours have been detected only along the west coast of 
North America. Immunosuppression is very important 
in viral-induced human cancers21, and it would be inter-
esting to know whether affected raccoons were immuno-
suppressed either at the time of RacPyV infection or at 
another relevant timepoint during tumour progression. 
Possible mechanisms of immunosuppression range 
from co-infection(s) to a regional environmental toxin. 
Regardless, the association of brain cancer with RacPyV 
and its episomal status in neuroglial tumours highlight 
novel potential consequences of PyV infection.
Although no other causal associations with cancer 
have been described, PyV infections have recently been 
detected in numerous wildlife species. The first carnivore 
PyV identified was extracted from a fibropapilloma on the 
tongue of a feral California sea lion31,32. In African great 
apes (chimps and gorillas), two new groups of PyVs were 
discovered that are most closely related to the oncogenic 
MCPyV, and ~30% (8/27) of the great ape populations 
tested carried detectable virus33. Wildlife-associated 
PyVs have also been identified in badgers34, Weddell 
seals35, sea otters36, wild rodents37, bats38,39, penguins40 
and Black Sea bass41. Their relationship with cancer, 
if any, has not been uncovered.
PVs and PyVs are taxonomically distinct, but they 
share striking similarities in their viral lifestyles, includ-
ing host persistence and their mechanisms of tumour 
induction. A demonstrative example of their close rela-
tionship is bandicoot papillomatosis carcinomatosis 
virus type 1 (BPCV1), which is a chimaera of structural 
and oncogenic elements of PyVs and PVs, respectively. 
The hybrid virus was discovered through its associ-
ation with cutaneous hyperplasia and carcinomas in 
the Australian Western barred bandicoot (Perameles 
bougainville)42. A remarkable 57% of 127 captive and 
free-ranging Western barred bandicoots in the prelim-
inary survey were affected with the hyperplasia and/or 
carcinoma syndrome42,43. The collective data suggest a 
causal relationship, but there is an unexpected anomaly 
in that the virus has not been detected in any clinically 
healthy individuals42. Given that PyVs and PVs are typ-
ically persistent, lifelong, innocuous infections wide-
spread in the host species, it would be interesting to 
understand the recombination mechanism and to know 
whether BPCV1 persists in the host and, if so, in which 
cell type and bandicoot species. Alternatively, BPCV1 in 
the bandicoot may be a transient infection that can lead 
to transformation.
A sizeable number of 170 human PVs are currently 
recognized, and it is likely that all animals serve as hosts 
for a range of species-specific PVs. We largely assume, 
regardless of species, that PVs propagate exclusively in 
an epithelial niche. From a comparative standpoint to 
other types of virus, PVs can have a broader tissue tro-
pism and host specificity44,45. Bovine deltapapillomavirus 
type 1 (BPV1) and BPV2, common in cattle, can also 
infect water buffalo, giraffe, tapirs, deer and zebras44–46. 
BPV1 and BPV2 can infect fibroblasts and can cause 
fibropapillomas46. Although little is known regarding 
recently identified avian and fish PVs, at least one avian 
PV (Fulmarus glacialis PV1 (FgPV1)) has been detected 
in mesenchymal cells of the northern fulmar (Fulmarus 
glacialis), a pelagic seabird47.
Herpesviruses. Otarine (eared seals) herpesvirus type 1 
(OtHV-1) is a gammaherpesvirus phylogenetically 
related to human herpesvirus 8 (HHV8; also known 
as Kaposi sarcoma herpesvirus (KSHV)), the caus-
ative agent of Kaposi sarcoma48. OtHV-1 may con-
tribute to urogenital carcinomas in feral California 
sea lions49–52 and has been detected in a single case of 
Fibropapilloma
a condition characterized by 
the presence of proliferative 
benign neoplasms containing 
superficial epidermal and 
subjacent dermal tissue.
SVZLV
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Tumour
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Olfactory
bulb
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Cribriform
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Fig. 2 | Raccoon polyomavirus-induced cellular transformation. a | Raccoon 
polyomavirus (RacPyV) transforms neural stem cells into neuroglial brain tumours along 
the rostral migratory stream (RMS) in the olfactory lobe. b | The route of entry for the virus 
into the host and the cellular events driving transformation are currently unknown.  
One possibility for the route of entry is through haematogenous spread of RacPyV into 
the neural stem cell niche of the subventricular zone (SVZ). c | Alternatively , airborne 
transmission may occur, with retrograde infection of olfactory nerves. Identifying how 
neural stem cells are infected will increase our understanding of the role tissue stem cells 
may play in persistent infections and neoplastic transformation. LV, lateral ventricle.
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urogenital carcinoma in a captive South American fur 
seal53. However, the criteria for causality remain limited 
to detection of the viral genome in tumour tissue. Like 
all persistent viruses, establishment of causality faces the 
obstacle that the virus is also detected in animals with-
out cancer54. Environmental toxin exposure, a genetic 
basis and variation in hormone receptor expression are 
other factors that have also been identified as potential 
contributors to urogenital carcinoma occurrence in 
Californian sea lions55,56.
Fibropapillomatosis found specifically in marine tur-
tles is associated with variants of Chelonid alphaherpes-
virus 5 (ChHV5)57. Dermal fibropapillomas and fibromas 
have been documented to various degrees in all marine 
turtle species, but the disease is most prevalent in green 
turtles (Chelonia mydas)3,58. Although most tumours 
appear benign, they can impair vision, obstruct the mouth 
or cloaca and impede swimming. Moreover, the forma-
tion of tumours in internal organs occurs in severe cases. 
Fibropapillomatosis is transmissible by experimental 
infection59, suggesting that the associated herpesvirus 
plays a primary aetiological role; however, environmen-
tal cofactors have also been proposed to contribute60–62. 
Regardless of the role of the virus, ecology studies on 
ocean life have had to consider a new dimension in 
potential transmission routes because water immersion 
is such a uniquely shared space. Waterborne infection is 
possible, as herpesviruses can be stable in water57, and 
ChHV5 DNA has been detected in marine leeches (genus 
Ozobranchus) in breeding grounds of the green turtle63.
Infection of wild mountain gorillas with a specific 
strain of lymphocryptovirus 1 (GbbLCV-1) was recently 
discovered64. GbbLCV-1 is closely related to the human, 
oncogenic Epstein–Barr virus (EBV), thus explaining 
why previous reports detected ubiquitous EBV expo-
sure, by serological assay, among gorillas65. Similar to 
EBV infection in humans, GbbLCV-1 primary infection 
occurs in infants, and latent infection was detected in 
peripheral white blood cells64. B cell lymphomas, a subset 
of which are caused by EBV infection in humans, were 
diagnosed in a single mountain gorilla within the group 
examined in this particular study, and GbbLCV-1 was 
detected by PCR in blood collected from this individual 
at the time of necropsy64.
Viral integration
Both DNA and RNA viruses can disrupt the host genome 
by integration, but examples of integration causing can-
cer among wildlife are currently limited to retroviruses. 
Studies of transmissible exogenous retroviruses have led 
to the recognition that all animals carry a large number 
of integrated endogenous retroviruses (ERVs)66. ERVs 
make up 5% and 4.7% of the mouse and human genome, 
respectively, and many of these so-called fossil viruses 
retain transcriptional and (at least in mice) replication 
capacity67. Given the ability of ERVs to move within the 
genome, distinguishing them from exogenous viruses 
and identifying their potential contributions to cancer 
are vital. There are important examples of studies in 
wildlife species that have achieved a requisite combina-
tion of epidemiological, transmission and in vitro data 
supporting causality.
Jaagsiekte sheep retrovirus (JSRV) and enzootic nasal 
tumour virus (ENTV) are the causative agents of pul-
monary and nasal carcinomas, respectively, in domestic 
sheep and goats68. Feral bighorn sheep spontaneously 
develop similar paranasal sinus tumours, and histo-
logical features and geographic clustering support an 
infectious aetiology69,70. The most convincing evidence 
for an infectious origin is that the tumours in bighorn 
sheep are transmissible through inoculation with a 
cell-free filtrate: within 18 months of inoculation, one 
of four bighorn sheep and, intriguingly, four of four 
domestic sheep developed tumours within ethmoid 
sinuses or nasal conchae69. However, PCR and immuno-
histochemistry failed to demonstrate the presence of 
ENTV or JSRV, so metagenomics, deep-sequencing and 
cell culture studies designed to uncover a viral cause are 
ongoing (S. L. Quackenbush, personal communication).
Gammaretroviruses (KoRVs) found in koalas 
(Phascolarctos cinereus) are in a unique state of evolu-
tionary adaptation. At least three variants have been 
identified, KoRV-A, KoRV-B and KoRV-J, each with 
varying associations with cancer71. KoRV-A is endoge-
nous and is rarely associated with cancer, while KoRV-B 
(a presently exogenous virus) is associated with lym-
phoma72. The lack of genetic diversity in the KoRV-A 
endogenous virus appears to be associated with its 
inability to induce tumours73. Whether KoRV-J is also 
associated with increased cancer incidence is still being 
investigated. Therefore, KoRVs might provide the 
opportunity to witness a retrovirus becoming embedded 
in the genome of its host, a phenomenon that has been 
only theorized in other species74.
Herpesviridae, Papillomaviridae and Retroviridae are 
all associated with the development of tumours in fish, 
but retroviruses are particularly well represented, with 
suggested involvement in 13 different piscine tumours75. 
Compelling evidence (in the form of sequencing, iso-
lation and transmission studies) for a causal role exists 
only for a few of these. Walleye dermal sarcoma virus 
(WDSV), an exogenous retrovirus that causes dermal 
sarcoma in walleye (Sander vitreus), encodes a cyclin- 
C-like homologue postulated to interfere with cell cycle 
regulation76,77. Experimental transmission with cell-free 
tumour filtrates has been successful by numerous trans-
mission routes (including intramuscular, oral and top-
ical)78 and has expanded the potential host range of the 
virus to other fish species79. The study of fish oncogenic 
retroviruses has an interesting and potentially exploit-
able angle on host tumour immunity. Many of these 
retroviral-associated fish tumours develop season-
ally, and their growth is linked to temperature-driven 
changes in the immune response of these fish (which 
are ectotherms), providing potentially valuable models 
of tumour regression80.
Toxin-related cancer
Wildlife populations encounter numerous anthropo-
genic pollutants, including industrial and agricultural 
waste, radiation and, increasingly, pharmaceutical con-
taminants81,82. These pollutants coexist with biota in a 
complex ecosystem. As we move towards a more inten-
sive agrarian and civic lifestyle worldwide, concentrated 
Cloaca
The caudal opening in reptiles, 
amphibians and birds used for 
digestive, reproductive and 
urinary tract excretions.
Retroviruses
RNa viruses that utilize reverse 
transcriptase to generate a 
complementary DNa strand 
from the RNa template, which 
is then integrated into the 
genome of the infected cell.
Nasal conchae
also called nasal turbinates. 
Convoluted, curled thin bones 
covered by respiratory 
epithelium that protrude into 
the breathing passage of 
animals.
Ectotherms
animals dependent on 
exogenous heat to maintain 
body temperature.
Agrarian
Relating to farmland, 
agriculture or the cultivation of 
land for crops.
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exposures are more likely for all. Ageing infrastructure, 
a global lack of governmental priority and regional water 
shortages may see the spread of environmental contam-
inants into water bodies or groundwater, affecting not 
only humans but also wildlife. Thus, studying the impact 
of environmental toxicology on cancer in wildlife has the 
potential not only to identify causal relationships that 
may affect humans but also to compare affected ver-
sus resistant species to identify evolutionary strategies 
inhibiting oncogenesis. Wildlife now frequently exist 
within changing environments, where large regions 
of mixed use (industrial, agricultural and residential) 
are increasingly becoming divided into more focused 
microenvironments, which reduce the ecosystem com-
plexity and biodiversity. How this change will affect 
cancer incidence and how it relates to concentrated 
environmental pollution highlight the importance of 
disease  surveillance in wild fauna.
Pollution may affect the cancer prevalence across 
wildlife species by diverse means. Historically, empha-
sis has been placed on the direct roles of xenobiotics 
or radiation-inducing somatic mutations that disrupt 
oncogenes or tumour suppressor genes83. While these 
are undoubtedly important, with mounting cases of 
documented contribution to wildlife cancer, these are 
perhaps over-represented because they are the easiest to 
identify as causal84–86.
Organochlorines and cancer
Beginning in the 1980s, hundreds of stranded California 
sea lions have been examined by the marine stranding 
network55. These animals display a strikingly high prev-
alence of metastatic urogenital carcinomas, with up to 
26% of adults having these tumours55. This aggressive 
and metastatic tumour appears to arise from the cervix 
and vagina in females and from the penis, prepuce and 
urethra in males. It exhibits similarities to human cervical 
intraepithelial neoplasia (CIN), with lesions that resem-
ble human CIN grades I to III55,87,88. Organochlorines 
(OCs) and polycyclic aromatic hydrocarbons (PAHs) 
are putative endocrine disrupting compounds (EDCs) that 
have both been associated with the development of these 
tumours89. While the mechanism of cancer formation 
in these animals remains complex (including potential 
contribution from herpesvirus infection), OCs remain 
relevant as potential factors, as they are environmentally 
persistent molecules that bioaccumulate and biomagnify 
within predators90.
Additional evidence for a contributory role of OCs 
in wildlife cancer can be found within beluga whales 
(Delphinapterus leucas) of the St. Lawrence Estuary, 
Quebec, Canada3,90. Over half of all cancers identified 
worldwide in toothed whales occur within this iso-
lated population of approximately 900 beluga whales90. 
Cancers are most often of gastrointestinal origin, which 
is important given the whales propensity to feed within 
the benthic zone, which is associated with contaminated 
sediment90. While OCs have largely been banned in the 
USA since the 1980s, their environmental persistence, 
particularly in aquatic sediment, remains a threat to 
wildlife91. Furthermore, in many countries, OCs are con-
tinually used as pesticides owing to their low cost and 
efficacy. Sediment containing high levels of OCs from 
regional runoff is often identified within the gastric con-
tents of beluga whales suffering from these malignan-
cies90. These findings are of particular interest as many 
scientists have linked OC exposure to gastric cancer in 
humans92,93. Accumulated OCs and PAHs in sediment 
have also been associated with increased liver and skin 
tumours in a variety of fish, including English sole, 
European flounder and brown bullhead90,94. Identified 
and proposed mechanisms of carcinogenesis from OCs 
and PAHs are shown in Fig. 3.
Endocrine disrupting compounds
EDCs may mimic vertebrate sex hormones, functioning 
as either an agonist or antagonist within a particular hor-
monal pathway, or may alter hormonal action through 
perturbations in hormone production, receptor bind-
ing or metabolism95. The World Health Organization 
(WHO) has recognized EDCs as a widespread envi-
ronmental contaminant owing to their multiple trans-
mission routes — ingestion, inhalation, trans-dermal 
contact and trans-placental spread96. It has designated 
EDCs as a global emerging issue, with concern over the 
effects of these compounds on fertility, birth defects and 
cancer formation. The strongest link between EDCs 
and human cancer has been demonstrated with breast 
cancer, but potential involvement of biologically active 
EDCs in both male and female reproductive tumours is 
also a concern97.
Wildlife encounter EDCs in much the same way that 
humans do — through ingestion, inhalation or skin 
contact. They are exposed to widely varying amounts 
of EDCs, and documentation of regional variation is 
important because, at nanomolar concentrations, EDCs 
primarily act through binding of nuclear receptors, but 
at millimolar concentrations, they may affect cell behav-
iour through epigenetic disruption98. EDCs implicated 
in wildlife cancer include dioxins, which are associated 
with an increasing prevalence of non-Hodgkin lym-
phoma in humans99. Dioxins have been detected from 
blubber and liver tissue in a single case of naturally 
occurring hepatosplenic lymphoma in a bottlenose dol-
phin and can drive dolphin lymphocyte proliferation 
in vitro100. In addition, examination of white suckers, 
a freshwater fish species in Lake Michigan tributaries, 
also indicates increased hepatic tumour prevalence 
 associated with EDC levels101.
Of increasing interest is the role of epigenetic dis-
ruption caused by EDCs. Indeed, this is now viewed as 
one possible explanation for their persistent biological 
effects. As endocrine hormonal mimics, EDCs princi-
pally act through binding of nuclear receptors, such as 
the oestrogen, androgen or thyroid receptors, to drive 
gene transcription102. Nuclear receptor activation may 
increase or decrease expression of key epigenetic path-
ways, including expression of DNA methyltransferases 
(DNMTs) and genes involved in the conversion of 
5-methylcytosine (5-mC; such as tet methylcytosine 
dioxygenase 1 (TET1) and TET2) and in histone mod-
ifications (such as histone acetyltransferase KAT2A 
(also known as GCN5) and histone deacetylase 1 
(HDAC1))103,104. Both nuclear receptors and EDCs may 
Xenobiotics
any substance (synthetic or 
natural) that is not naturally 
present in the body of an 
organism.
Endocrine disrupting 
compounds
(eDCs). a broad category of 
mostly man-made substances 
that are present in pesticides, 
plastics, personal care 
products, metals and 
pharmaceuticals, among many 
other items, which result in 
altered hormonal activity via 
agonistic and antagonistic 
receptor binding.
Bioaccumulate
When a substance becomes 
concentrated within the body 
of a living thing. if the source of 
the substance is from water, 
this is specifically referred to as 
bioconcentration.
Biomagnify
The increasing concentration of 
a substance within the tissues 
of an organism acquired 
through predatory acquisition 
(a food chain).
Benthic zone
The lowest ecological regions 
of a body of water, such as the 
sediment surface.
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regulate non-coding RNA expression, including long 
non-coding RNA, such as HOX transcript antisense 
RNA (HOTAIR), which is implicated in the develop-
ment and progression of human cancers105,106. This com-
plex interplay explains in part why one would expect 
EDCs to alter the epigenetic environment of a cell, 
potentially promoting carcinogenesis, but mechanistic 
studies in specific cancers are still lacking107. As these 
pathways are highly conserved across mammals, more 
research effort should be funded to evaluate the impact 
of epigenetic alterations on oncogenesis in environmen-
tal contaminant-associated wildlife disease. Studies that 
may be difficult to perform in disparate human popula-
tions may be easily achieved through looking at relative 
population bottlenecks in wildlife, such as the beluga.
It is unlikely that environmental contaminants func-
tion solely as mutagens within cancer development; 
rather, they operate through multiple mechanisms. One 
such mechanism may be immunosuppression. While 
research into environmental toxicants often centres 
on their non-communicable disease status, it is a mis-
take to dissociate them from any impact on the host 
immune system or potential role in the acquisition of 
infectious disease. Through either direct or indirect 
means (whereby increased organismal energy expend-
iture must be spent to overcome the deleterious effects 
of pollution), environmental toxins may predispose ani-
mals to infection by oncogenic pathogens (viral, bac-
terial or parasitic). Many of the same compounds that 
are associated with tumour formation in humans and 
wildlife, such as OCs (including polychlorinated biphe-
nyls (PCBs)), dioxins and other EDCs, may be immuno-
suppressive or alter the immune reaction to infectious 
disease108,109. Furthermore, environmental pollutants 
likely act throughout cancer initiation, promotion and 
progression to assert changes in biological function in 
addition to increasing genomic stress. A zebrafish model 
indicates that the OC pentachlorophenol may produce 
Warburg-like effects by interfering with oxidative phos-
phorylation in cells, mimicking the altered cellular 
metabolism commonly identified in human tumours110.
Reproduction-related cancers
The remarkable proliferative capacity of the reproduc-
tive tract makes it a common site for cancer, and this 
susceptibility creates risks beyond the overall fitness of 
the animal, such as impaired fecundity. Poaching, habi-
tat destruction, competition for resources with humans 
and invasive species play a more evident role in the 
decline of populations. However, reduced populations 
are more susceptible to any additional negative factors, 
and decreased fecundity due to neoplasias affecting the 
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Fig. 3 | Toxin-mediated oncogenesis. This schematic depicts the molecular mechanisms of carcinogenesis induced by 
environmental contaminants. Organochlorines (OCs), polycyclic aromatic hydrocarbons (PAHs) and many endocrine 
disrupting compounds (EDCs) are lipophilic and, thus, are easily absorbed across the plasma membrane of cells171. OCs 
and PAHs may directly damage biomolecules, but most require bioconjugation by the cytochrome P450 (CYP450) system 
to generate reactive intermediates172. These are then capable of inducing DNA damage, including G > T transversions 
during DNA replication characteristic of some PAHs173,174. OCs and EDCs alter mitochondrial function, decreasing the 
activity of cytochrome c oxidase (COX) subunits and superoxide dismutase (SOD), leading to reactive oxygen species 
production and cellular damage175. Additionally , many of these compounds are hormonal mimics, resulting in altered gene 
expression176. Finally , many EDCs have been shown to modulate the expression of regulatory long non-coding RNAs 
(lncRNAs) and microRNAs (miRNAs) both in vitro and in vivo, including several candidate oncomiRs (miRNAs associated 
with cancer)177. DSBs, double-strand breaks; ER , endoplasmic reticulum; HREs, hormonal response elements.
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reproductive system may have increased impact for 
small populations. Smaller populations of free-ranging 
animals replicate, to some degree, the limitations of zoo 
populations. Captive animals receive medical treatment, 
are on standardized diets and are held in high popula-
tion densities, and their reproduction is often controlled 
medically or by separation; however, increasingly, 
wild populations are being more individually managed 
than in the past, making the differences between wild 
 populations and captive animals less disparate.
Limited genetic diversity in small gene pools can lead 
to decreased fitness in populations but can also allow 
the rapid increase in prevalence of deleterious genes111. 
Small populations can also limit breeding opportunities, 
leading to abnormal social structures, fewer pregnancies, 
as well as pregnancies that occur later in the animal’s 
life, and a corresponding decrease in overall reproduc-
tive health112,113. The concept of evolutionary mismatch 
provides a model for these types of population effects 
and can be likened to the neoplastic diseases associ-
ated with nulliparity in women114,115. Many fragmented 
populations are also exposed to environments contami-
nated with toxins affecting reproduction, making it dif-
ficult to tease out the relative impact each factor might 
have. Furthermore, rates of potentially cancer-causing 
pathogen transmission might be anticipated to be dif-
ferent between smaller, denser populations and larger, 
free-ranging populations. There might also be a greater 
exposure to zoonotic agents as humans impinge on 
these populations.
An example of the effects of limited genetic diversity 
is seen in the Florida panther (Puma concolor coryi), an 
Endangered (U.S. Fish and Wildlife Service Endangered 
Species) and inbred species, with one study showing 
that 11 of 17 (65%) individuals had cryptorchidism116. 
Cryptorchidism is a highly heritable trait that is also 
associated with exposure to endocrine disruptors, 
such as 1,1-dichloro-2,2-bis(p-chlorophenyl)ethylene 
(p,p’-DDE), a breakdown product of dichlorodiphenyl-
trichloroethane (DDT), mercury and PCBs117. In 
addition to the negative effects on spermatogenesis, cryp-
torchidism is linked to the development of seminomas 
and Sertoli cell tumours, although no testicular cancer has 
been specifically identified in the limited surveys so far 
carried out on Florida panthers116,118. A similar high rate 
of cryptorchidism has been reported in a population of 
Sitka black-tailed deer (Odocoileus hemionus sitkensis) 
restricted geographically to Kodiak Island (Alaska, 
USA), although reproductive system cancers were also 
not identified in this limited observational study119.
A Near Threatened (IUCN Red List) species, the 
jaguar (Panthera onca), whose population is carefully 
managed in captivity, has shown an alarmingly high 
incidence of ovarian carcinoma in USA captive pop-
ulations, leading to death or euthanasia120–124. These 
findings are reminiscent of women with mutations in 
BRCA1 or BRCA2 genes125, and although a large num-
ber of candidate genes have now been found in jaguars, 
further analysis will be required to identify specific 
mutations in the genes correlating with tumorigenesis123. 
Similar cancers have been only anecdotally reported in 
free-ranging jaguars, highlighting the challenges of such 
investigations in the field and the value of zoo collections 
in better understanding the interactions of genetics, 
environment and disease. Furthermore, while genetic 
analyses are possible from small samples of skin, blood, 
hair or even faeces, substantial political impediments to 
sharing biological materials across international bor-
ders make it difficult or impossible to effectively col-
laborate with conservation scientists in countries where 
these species are free-ranging. Laws intended to protect 
endangered species can often make the science required 
to effect such protection unfeasible126.
A more subtle effect of less frequent pregnancy is a 
reduction in future fertility, an increasingly recognized 
phenomenon of evolutionary mismatch seen in captive 
populations of wild mammals and often described as ‘use 
it or lose it’115,127. Hormonal stimulation, particularly by 
oestrogen, can produce marked proliferative responses 
from the uterine, cervical, vaginal and mammary epi-
thelium and smooth muscle128. Such stimulation would 
be infrequent in the wild, as females would become 
pregnant on their first estrous cycle, spend a consider-
able time span being pregnant or lactating and would 
then become pregnant again shortly after they began to 
cycle again. One study of the reproductive pathology of 
white rhinoceros estimates that a free-ranging female 
would have 30–90 estrous cycles in a typical lifetime, 
with the majority of its adult lifespan spent in lactation 
or pregnancy129. However, females held in captivity 
in a non-reproductive state (that is, separated from a 
fertile male) would experience greater than 300 cycles, 
exposing the reproductive tract to an oestrogen-rich, 
proliferative hormonal milieu up to ten times more 
frequently. This leads to progressively decreased fertil-
ity and an increase in proliferative and neoplastic dis-
eases, collectively described as asymmetric reproductive 
ageing129 (Fig. 4).
An example highlighting how pregnancy can provide 
a natural protective mechanism against asymmetric 
reproductive ageing processes is the observation that 
leiomyomas and cystic endometrial hyperplasia have been 
reported in nearly all nulliparous captive white rhinos 
yet are very rare in multiparous reproductively active 
animals129. This scenario is poignantly demonstrated 
by the critically endangered northern white rhino 
(Ceratotherium simum cottoni), in which such lesions 
have been described in nearly all remaining females, 
making this species functionally extinct129. A similar 
prevalence of these lesions has also been reported in the 
Indian rhinoceros (Rhinoceros unicornis)130. Captive, 
aged chimpanzees, largely kept in non-reproductive 
conditions, have a leiomyoma incidence of 40–62% 
(4/10 in one study and 20/32 in another)131,132, yet the 
number in wild populations has not been accurately 
estimated. In addition to environmental toxins, the inci-
dence of reproductive system cancers in manatees may 
also be associated with increasing urban encroachment 
and fragmentation of their range, leading to isolation 
of individuals and difficulty in finding mates133. The 
continued monitoring of a wild population of moun-
tain gorillas in central Africa provides one of the few 
opportunities to compare free-ranging and captive 
populations: interestingly, no leiomyomas have been 
Evolutionary mismatch
a concept in evolutionary 
biology referring to the 
presence of once beneficial 
traits in a population that, 
owing to rapid environmental 
change, are no longer 
beneficial but harmful.
Cryptorchidism
The absence of one or both 
testes from the scrotum, 
usually resulting from a failure 
to descend during 
development.
Seminomas
a type of germ cell tumour of 
the testicle.
Sertoli cell tumours
a sex cord-gonadal stromal 
tumour composed of Sertoli 
cells, which line the 
seminiferous tubules and help 
in the development of sperm. 
These are typically benign and 
often hormonally active.
Estrous cycle
The recurring cyclic variation in 
reproductive hormones (for 
example, oestrogen and 
progesterone) in the 
mammalian female that 
controls behaviour, 
reproductive organ 
morphology, ovulation and 
conception.
Leiomyomas
When present in the 
reproductive tract (vagina, 
cervix, uterus, oviduct or 
ovary), these are hormonally 
responsive benign smooth 
muscle tumours. in humans, 
these are also known as 
fibroids.
Cystic endometrial 
hyperplasia
a condition of excessive 
proliferation of the glandular 
epithelium of the uterus, 
typically associated with 
excessive progesterone and/or 
oestrogen stimulation.
Nulliparous
an animal that has never given 
birth.
Multiparous
an animal that has given birth 
multiple times.
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reported in the free-ranging population of approxi-
mately 900 individuals, while one of nine reproductive 
tracts available for evaluation from captive gorillas had 
leiomyomas131. Similar effects have been seen in women, 
where early pregnancy and numbers of pregnancies sig-
nificantly decrease the risk of some subtypes of breast 
cancers later in life, and multiparous women have a 
greatly reduced risk of leiomyomas than nulliparous 
women134–136.
In sexually intact domestic dogs and cats, when they 
cycle but do not conceive, they are exposed not only to 
high levels of oestrogen but also to high endogenous lev-
els of progesterone during diestrus. In these species, and 
in wildlife species with similar cycles such as African 
painted dogs or lions, the endogenous high hormonal 
levels are also suspected to predispose these animals to 
increased mammary cancer137,138. The use of progestin 
contraceptives in zoos only increases this effect, resulting 
in many mammary cancers in tigers as well as other car-
nivores, unless animals are periodically allowed to breed 
and carry a fetus to term139. While contraceptives are not 
commonly used in free-ranging populations, similar 
effects might be expected in some species if breeding 
opportunities are less frequent.
Another manifestation of human impact on animal 
populations may be the loss of predators in many eco-
systems; large predators are often targeted by humans 
as a result of hunting for sport, out of fear for personal 
safety or to protect livestock140. It is likely that in these 
cases, prey animals will have longer lifespans, with 
corresponding increases in cancer, similar to humans 
when the reduction of infectious diseases and modern 
health care increased life expectancies. An example of 
this is a semi-wild population of fallow deer managed 
in an urban park island effectively free from predation 
for over 100 years where population control was finally 
achieved following sterilization of all the males (D. A., 
unpublished observations). Ten to 12 years after this 
population control, many females were found to be 
nulliparous or had only produced fawns much earlier 
in their lifetime, and most had developed endometrial 
hyperplasia, endometrial carcinoma, cervical carcino-
mas and leiomyomas. However, as might be expected, 
multiple factors are likely to play a role, including age, 
prolonged hormonal stimulation without pregnancy 
(asymmetric reproductive ageing), potential toxins in 
an urban environment and genetics (inbreeding).
Transmissible cancer
One of the most unique cancers in the animal and 
human world is transmissible venereal tumour (TVT) 
of the dog, which is also seen in other canids3,141. In 
this disease, a neoplastic population of cells is trans-
mitted during coitus, upon which the cells implant on 
the mucosa of the new host and persist until a vigorous 
host immune response causes tumour regression142,143. 
Recent work shows that the tumour regression (either 
spontaneous or following vincristine chemotherapy) is 
sequential and dependent on host innate immunity144. 
After tumour development, the host innate immune sys-
tem is activated, leading to remodelling of host epithe-
lium, immune cell infiltration of the tumour, cell cycle 
arrest within the tumour cells and, finally, repair of host 
tissue damage. Specific cytokines (especially C-C motif 
chemokine ligand 5 (CCL5; also known as RANTES)) 
were identified as key players, in addition to changes in 
gene expression associated with methylation of tumour 
cell DNA144. Since 1876 when it was first described145, 
TVT was thought to be the only naturally transmissible 
tumour in nature; however, in 1996, a new transmissi-
ble tumour was identified, affecting the already endan-
gered Tasmanian devil (Sarcophilus harrisii), known as 
devil facial tumour disease (DFTD)146. This tumour is 
transmitted between devils during social interactions, 
including mating. Such interactions are often violent 
and may result in oral and facial wounds where the 
tumour cells are implanted. Subsequent proliferation of 
the tumours leads to disfigurement and facial damage 
sufficient to cause starvation and death147. Intriguingly, 
tumours affect the most reproductively fit animals, 
Diestrus
a non-receptive phase of the 
estrous cycle dominated by 
progesterone production.
Pregnant Non-pregnant
Natural state Hyperplasia Progression to cancer
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Parturition and
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Repeated cycles without
pregnancy or remodelling
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Fig. 4 | Reproductive system cancers in wildlife. In the normal, natural state, adult wild animals are typically pregnant or 
lactating. During brief non-pregnant states, animals have short hormonally driven estrous cycles, which typically result in 
another pregnancy. Pregnancy , parturition and post-partum involution result in extensive remodelling of the uterine 
endometrium and removal of hyperplastic tissue. However, if pregnancy does not occur regularly owing to factors such as 
skewing of sex ratios, captivity or other abnormal pressures on a population, repeated estrous cycles may occur with 
elevated and prolonged hormonal exposure, leading to hyperplasia without remodelling as might occur during 
parturition and involution. This phenomenon of asynchronous reproductive ageing can lead to inflammation, infertility 
and hormonally driven cancers, such as leiomyomas.
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thus spreading more rapidly through the population147. 
This tumour clone (known as DFTD1) and a similar 
but distantly related tumour clone (DFTD2) also iden-
tified in Tasmanian devils indicate that transmissible 
tumours may not be as rare as was once thought and 
that these diseases threaten to make this species extinct 
in a matter of a few short generations148. Tasmanian 
devils have experienced a succession of population 
crashes or bottlenecks, which have greatly limited their 
genetic diversity149. The inability of Tasmanian devils to 
reject implanted tumour cells was proposed to be the 
catastrophic event of a reduction in major histocom-
patibility complex (MHC) diversity in the Tasmanian 
devil population150; however, more recent work suggests 
that tumour cells downregulate the expression of MHC 
proteins via epigenetic mechanisms149. Further, DFTDs 
show no evidence of exposure to exogenous mutagens or 
viruses and despite being allogeneic grafts, DFTDs need 
to escape the host immune system. This requires hemi-
zygous loss of β2-microglobulin (B2M), which encodes 
a component of MHC class I in DFTD1, suggesting that 
there is selection to escape immune detection151. This 
work has also shown sensitivity of both tumour clones 
to tyrosine kinase inhibitors151.
Similarly, once-flourishing populations of soft-shelled 
clams (Mya arenaria) are now at risk of extinction as a 
result of horizontally transmitted neoplastic haemocytes 
derived from a single clonal origin, likely spread from 
clam to clam by currents141,152. Furthermore, four inde-
pendent disseminated cancer lineages have since been 
identified in three other bivalve species152. Collectively, 
while these transmissible tumours are relatively rare 
events in the overall incidence of cancer in natural wild-
life populations, the rapid endangerment of species, such 
as the Tasmanian devil, highlights the potential for such 
an event to have a catastrophic effect.
With respect to the potential relevance of transmis-
sible cancers to human health, a recent report demon-
strated that malignant, genetically altered stem cells 
from the cestode Hymenolepis nana, which normally 
infects and inhabits the intestines, had spread to other 
organs in an immunocompromised human infected 
with HIV153. The infection resulted in the death of the 
patient. This phenomenon may not be novel but simply 
under-reported or misreported, as earlier descriptions 
of similarly abnormal transformed cells from parasites 
disseminating in multiple species of hosts, including 
humans, were labelled with different terminology, such 
as “aberrant” or “anomalous” infections154.
Challenges
There are many reasons the occurrence of cancer in var-
ious wildlife populations could be underestimated. With 
a few exceptions, surveillance programmes are limited 
and are often targeted to specific diseases or pathogens. 
Neoplasia that has not yet resulted in substantial mor-
bidity may go unrecognized, particularly if lesions are 
small or affect only internal organs. If neoplasia does 
result in mortality, carcass attrition may limit discovery. 
Caution is also warranted in interpreting the data that 
are available. Recently, researchers noted the apparent 
lack of cancer in elephants and suggested a possible 
association with the presence of additional copies of the 
TP53 gene (pseudogenes)155. However, others have noted 
that cancer is likely under-reported in elephants156.
Long-term mortality investigations in wildlife are 
rare, but they provide valuable insights into the poten-
tial impacts of cancer. Neoplasia might have limited 
impact on some populations, but other studies indi-
cate a substantial rate of cancer. As discussed above, 
the long-term investigation of beluga mortality in the 
St. Lawrence Estuary revealed the potential impacts of 
cancer in that population90; the focused examination 
of Santa Catalina Island foxes led to recognition of aural 
neoplasms14; and systematic collection of pinnipeds 
(aquatic fin-footed mammals) on the California coast 
resulted in the documentation of genitourinary carcino-
mas among California sea lion49. Susceptibility could be 
increased in a given population owing to genetic back-
ground, oncogenic viruses or other agents. Looking at 
taxa inclusive of multiple species could easily result in a 
lack of statistical significance for a given species. Many 
mortality reports look at broader taxa, for example, all 
reptiles in a given region, and it is unlikely that indi-
vidual species are sufficiently represented to assess the 
potential impacts of neoplasia.
Animals with occult lesions may be overlooked with-
out detailed examinations by trained professionals, but 
the large, destructive tumours of DFTD are easily rec-
ognized141,147. However, cases of urothelial carcinoma in 
the bladders of feral, white-tailed deer (Odocoileus vir-
ginianus) were difficult to identify without a thorough 
examination of the mucosa at necropsy and confirmation 
by histopathology, and it is likely that under-reporting of 
such lesions has resulted from inadequate examination 
(M.K.K., unpublished observations)157.
Estimates of morbidity and mortality in wildlife due 
to spontaneous disease are generally very difficult, and 
much of the problem lies in the challenges of detecting 
affected individuals. If a particular type of cancer affects 
a small percentage of the population, it could easily be 
missed owing to the inherent difficulty in detecting car-
casses. For animals as small as passerine birds, more than 
75% of the carcasses may disappear owing to scavenging 
or decay within the first day after death158. Even carcasses 
of large ungulates can be surprisingly difficult to find. 
An outbreak of haemorrhagic disease in one white-tailed 
deer population resulted in 8% mortality that was con-
firmed by tracking radio-collared individuals. However, 
the state wildlife department did not receive any reports 
of sick or dead deer during that outbreak159. Without sys-
tematic surveillance, smaller animals dying of cancer at a 
less dramatic rate are likely to be undiscovered.
More thorough examination of mortality events is 
warranted to document disease threats to wild popu-
lations. Many of the forerunners of modern wildlife 
biology felt that disease was secondary to habitat, and 
mortality due to disease did not place populations 
(or species) at undue risk. However, wildlife diseases 
with unmitigated impacts on populations have begun 
to emerge at an alarming rate. Anthropogenic factors 
may be a factor in such disease emergence and have been 
confirmed in many cases (for example, toxins, dissem-
ination of infectious agents and genetic bottlenecks). 
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In other cases, the origins are less certain. Regardless, 
disease threats, including cancer, continue to place our 
wild populations at risk.
Future directions and conclusions
Owing to the difficulty in acquiring case material dur-
ing an outbreak and the relative rarity of recognized 
disease outbreaks in wild animals (both captive and 
free-ranging), support for archiving of biological speci-
men collections is critical. This is important for animals 
collected during mortality events, as well as collections 
of samples from unaffected animals, as the latter can 
provide very important baseline data. Potential dis-
ease outbreaks are often identified only after anecdo-
tal reports accumulate to a critical level and valuable 
biological material has not been collected, discarded or 
lost. Continuous monitoring of cancers in wild animals 
is needed, as well as collation and archiving of tissues 
(biobanks) to test the potential cause or causes of those 
cancers160. In addition, documentation of the wide diver-
sity of endocrine and reproductive patterns, develop-
ment of tools to estimate stress and studies of the genetic 
or environmental associated immunosuppression in the 
animal kingdom will improve our ability to correlate 
disturbances in the natural history of individual species 
with increased incidences of cancer.
The study of how evolutionary bottlenecks affect 
cancer predisposition and outcome in wildlife also has 
ramifications for human cancers. Founder effects have 
been identified that predispose ethnic populations to 
breast, ovarian, prostate and colorectal cancers161–164. As 
our ability to interrogate complex data sets in the age of 
‘big data’ grows, it is possible to evaluate how cancer is 
affected by ancestral and spontaneous genetic polymor-
phisms as well as the environment. Favé et al.165 recently 
published an intriguing method for the computational 
analysis of genetic and environmental interactions in 
determining disease. Performing similar analyses across 
wildlife cancer would undoubtedly reveal more infor-
mation regarding the role of putative tumour suppres-
sors and oncogenes and how our changing environment 
 dictates outcomes like cancer.
Tumour prevalence varies greatly across the wide 
variety of animals, and studying wildlife cancer can 
provide us with an appreciation of the varied mech-
anisms of oncogenesis. The so-called Peto’s paradox 
asks why cancer incidence is not directly related to the 
number of cells in an organism and lifespan166. If we 
believe that cancer exists as a result of the combined 
influences of endogenous and exogenous genomic 
stressors, chronic inflammation and infectious dis-
ease, the immune system, and inherent variation in 
cell biology, assessing the contribution of multiple fac-
tors, such as pathogen infection and environmental 
pollutants on cancer formation, is a prime example 
of how wildlife oncology stands to address the ques-
tion of Peto’s paradox. An example highlighting this 
is why California sea lions are susceptible to urogeni-
tal carcinoma, but other marine mammals that share 
exposure to the same (or similar) environment are not. 
Therefore, examining several animal species within a 
particular ecosystem is likely to help reveal both mech-
anisms of cancer resistance as well as species-specific 
biological processes that are requisite for cancer 
formation167.
The role wildlife can play as both a sentinel for novel 
threats to humankind and as models for as yet unrec-
ognized or poorly understood mechanisms of cancer 
development cannot be underestimated. Wild popula-
tions provide clues to the very basic questions regarding 
the origin, evolution and likely consequences of cancer 
on a population level. Studies of cancers in wild popu-
lations due to the interplay between host defences and 
infectious agents, environmental toxins (natural and 
man-made) and the disturbed proliferative capacity of 
the reproductive tract can provide useful information for 
human health and make the challenges associated with 
this research worth the effort. Furthermore, the benefit 
such a study provides for the preservation of the wildlife 
in our shared world is all the more reason to turn our 
investigative resources away from the bench and towards 
the wilderness.
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